Advertisement
- United Kingdom
- /
- Luxury
- /
- LSE:DOCS
Dr. Martens First Half 2025 Earnings: UK£0.022 loss per share (vs UK£0.019 profit in 1H 2024)
Dr. Martens (LON:DOCS) First Half 2025 Results
Key Financial Results
- Revenue: UK£324.6m (down 18% from 1H 2024).
- Net loss: UK£20.8m (down by 210% from UK£19.0m profit in 1H 2024).
- UK£0.022 loss per share (down from UK£0.019 profit in 1H 2024).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Dr. Martens Earnings Insights
Looking ahead, revenue is forecast to grow 5.0% p.a. on average during the next 3 years, compared to a 6.6% growth forecast for the Luxury industry in Europe.
Performance of the market in the United Kingdom.
The company's shares are up 17% from a week ago.
Risk Analysis
You should learn about the 4 warning signs we've spotted with Dr. Martens (including 1 which is potentially serious).
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About LSE:DOCS
Dr. Martens
Engages in the design, development, procurement, marketing, sale, and distribution of footwear.
Adequate balance sheet with slight risk.
Similar Companies
Market Insights
Advertisement
Weekly Picks
DA
davidlsander on Ubisoft Entertainment ·
Is Ubisoft the Market’s Biggest Pricing Error? Why Forensic Value Points to €33 Per Share
Fair Value:€33.886.2% undervalued
58 followersusers have followed this narrative
5 commentsusers have commented on this narrative
25 likesusers have liked this narrative
TO
Tokyo on LVMH Moët Hennessy - Louis Vuitton Société Européenne ·
EU#4 - Turning Heritage into the World’s Strongest Luxury Empire
Fair Value:€750.0428.3% undervalued
5 followersusers have followed this narrative
1 commentusers have commented on this narrative
9 likesusers have liked this narrative
WE
WealthAP on Alphabet ·
The "Easy Money" Is Gone: Why Alphabet Is Now a "Show Me" Story
Fair Value:US$386.4316.1% undervalued
66 followersusers have followed this narrative
1 commentusers have commented on this narrative
20 likesusers have liked this narrative
Recently Updated Narratives
PI
PittTheYounger on Delta Air Lines ·
Delta loses shine after warning of falling travel demand, but still industry leader
Fair Value:US$63.2118.7% overvalued
18 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
RA
Ravedigga on Defence Holdings ·
Project Ixian Accelerated Rollout will Drive Valuation Expansion to £0.0150.
Fair Value:UK£0.01510.7% undervalued
4 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
TO
Tokyo on Siemens ·
EU#5 - From Industrial Giant to the Digital Operating System of the Real World
Fair Value:€319.519.9% undervalued
3 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Popular Narratives
OO
OOO97 on Neo Performance Materials ·
Undervalued Key Player in Magnets/Rare Earth
Fair Value:CA$25.3317.8% undervalued
76 followersusers have followed this narrative
0 commentsusers have commented on this narrative
20 likesusers have liked this narrative
DA
davidlsander on Ubisoft Entertainment ·
Is Ubisoft the Market’s Biggest Pricing Error? Why Forensic Value Points to €33 Per Share
Fair Value:€33.886.2% undervalued
58 followersusers have followed this narrative
5 commentsusers have commented on this narrative
25 likesusers have liked this narrative
BL
BlackJesus on Adobe ·
The Strategic Revaluation of Adobe: A Critical Analysis of Market Sentiment
Fair Value:US$46042.0% undervalued
34 followersusers have followed this narrative
2 commentsusers have commented on this narrative
22 likesusers have liked this narrative
Trending Discussion
KA
Kalibrator on Ubisoft Entertainment ·
As a gamer, I would not touch this company now. They are hated by the community and have been releasing major flops on their AAA games during the last 5 years (for good reasons). It is true that the valuation is ridiculously low compared to what the licenses are worth, but if the trend continues the value of those will also decline. Management needs to almost make a 180° turnaround to get things right. I agree that a take-private deal before it is too late might be the best option for an investor entering today. We might also see a split sales of the different studios. It is a very risky play, but potentially with high reward.
1
|0